louisiana semaglutide nausea law office allows telehealth for obesity treatment with GLP-1 drugs semaglutide vomiting attorney in louisiana

Semaglutide as a Cardiovascular Disease Modifier: Semaglutide belongs to the class of medications known as glucagon-like peptide-1 receptor agonists (GLP-1 RAs), which have been found to offer cardioprotective effects beyond glycemic control

The dietary strategies outlined in this guide apply to both medications, but tirzepatide users may need to be even more aggressive about small, frequent meals during the adjustment phase

Consider asking your healthcare provider these questions: Given my weight loss and current dosage, are these cycle changes expected

Patients who stop the medication gain back on average two thirds of the weight they had lost